CLDI Calidi Biotherapeutics, Inc.

Fundamentals / CIK 0001855485 / USD
Other share classes on CIK 0001855485: CLDWW

Calidi Biotherapeutics, Inc. reported $5.52M in total assets and a net loss of $15.97M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CLDI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$3.13M$1.56M$0-$27.32MFY 2022 Revenue: $45KFY 2022 Net Income: -$25.43M2022FY 2023 Net Income: -$29.22M2023FY 2024 Net Income: -$22.14M2024FY 2025 Net Income: -$19.91M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $45K
Research & Development $9.74M $8.88M $13.01M $7.26M
Selling, General & Admin $10.50M $12.90M $15.98M $15.90M
Total Operating Expenses $20.24M $21.78M $28.99M $23.17M
Operating Income -$20.24M -$21.78M -$28.99M -$23.13M
EBITDA -$18.59M -$20.24M -$28.60M -$22.87M
Interest Expense $100K $700K $1.10M $200K
Income Before Tax -$20.05M -$22.20M -$29.20M -$25.42M
Income Tax Expense $15K $14K $16K $11K
Net Income -$19.91M -$22.14M -$29.22M -$25.43M
Basic EPS -$95.20 -$571.20 -$277.28 $478.40
Diluted EPS -$95.20 -$571.20 -$277.28 $478.40
Basic Shares Outstanding 269 42 105.4K 53.2K
Diluted Shares Outstanding 269 42 105.4K 53.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $2.70M $2.56M $2.59M $2.36M $2.36M $2.59M $2.42M $1.81M
Selling, General & Admin $1.64M $1.59M $1.60M $2.11M $2.69M $3.07M $2.64M $2.21M
Total Operating Expenses $4.34M $4.15M $4.19M $4.47M $5.05M $5.66M $5.06M $4.03M
Operating Income -$4.34M -$4.15M -$4.19M -$4.47M -$5.05M -$5.66M -$5.06M -$4.03M
EBITDA -$3.93M -$3.71M -$3.76M -$4.04M -$4.62M -$5.26M -$4.67M -$3.93M
Interest Expense $23K $22K $22K $0 $27K $40K $100K $100K
Income Before Tax -$3.64M -$4.16M -$4.10M -$4.06M -$5.17M -$5.76M -$5.06M -$4.14M
Income Tax Expense $9.0K $5.0K $4.0K -$2.0K $10K $4.0K $3.0K $3.0K
Net Income -$3.65M -$4.16M -$4.11M -$4.06M -$5.15M -$5.71M -$4.99M -$4.10M
Basic EPS -$1.47 -$47.04 -$6.88 -- -$35.25 -$508.00 -$35.36 --
Diluted EPS -$1.47 -$47.04 -$6.88 -- -$35.25 -$508.00 -$35.36 --
Basic Shares Outstanding 2.5M 88.5K 644.2K -- 307.0K 11.2K 141.1K --
Diluted Shares Outstanding 2.5M 88.5K 644.2K -- 307.0K 11.2K 141.1K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $5.60M $9.60M $1.95M $372K $1.06M
Cash & Short-Term Investments $5.60M $9.60M $1.95M $372K $1.06M
Accounts Receivable, Net -- -- -- $870 $0
Total Current Assets $6.26M $10.23M $4.30M $786K $1.48M
Property, Plant & Equipment, Net $781K $869K $1.27M $1.27M --
Other Non-Current Assets $19K $152K $373K $725K --
Total Non-Current Assets $2.60M $3.96M $5.72M $42.45M $230.3M
Total Assets $8.86M $14.18M $10.02M $2.60M $231.8M
Accounts Payable -- -- -- $51K $64K
Short-Term Debt $90K $3.22M $807K $5.42M --
Total Current Liabilities $3.94M $9.50M $10.23M $42.99M $411K
Long-Term Debt $510K -- $1.25M -- --
Other Non-Current Liabilities -- -- $1.50M -- --
Total Non-Current Liabilities $1.16M $2.72M $8.02M $1.07M $16.04M
Total Liabilities $5.10M $12.21M $18.25M $43.44M $16.45M
Total Debt (incl. Leases) $2.56M $6.48M $6.43M $5.99M --
Common Stock $1.0K $2.0K $1.0K $2.0K --
Retained Earnings -$141.6M -$121.7M -$99.57M -$70.36M -$14.69M
Accumulated Other Comp. Income -$13K -$28K -$47K -$14K --
Total Stockholders' Equity $3.76M $1.53M -$8.23M -$50.44M -$31.61M
Total Equity $3.76M $1.97M -$8.23M -$50.44M -$31.61M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $3.95M $4.07M $6.63M $5.60M $10.38M $5.28M $10.56M $9.60M
Cash & Short-Term Investments $3.95M $4.07M $6.63M $5.60M $10.38M $5.28M $10.56M $9.60M
Total Current Assets $4.74M $5.43M $7.35M $6.26M $11.03M $6.05M $11.49M $10.23M
Property, Plant & Equipment, Net $704K $775K $758K $781K $849K $929K $795K $869K
Other Non-Current Assets $0 $9.0K $138K $19K $140K $40K $144K $152K
Total Non-Current Assets $787K $1.78M $2.24M $2.60M $3.00M $3.30M $3.58M $3.96M
Total Assets $5.52M $7.20M $9.59M $8.86M $14.03M $9.35M $15.06M $14.18M
Short-Term Debt $668K $45K $23K $90K $472K $820K $1.16M $3.22M
Total Current Liabilities $3.73M $3.24M $3.84M $3.94M $5.19M $5.35M $5.43M $9.50M
Long-Term Debt -- $555K $577K $510K $128K -- -- --
Total Non-Current Liabilities $166K $834K $820K $1.16M $1.64M $1.92M $2.34M $2.72M
Total Liabilities $3.89M $4.07M $4.66M $5.10M $6.83M $7.28M $7.76M $12.21M
Total Debt (incl. Leases) $1.02M $1.94M $2.26M $2.56M $2.90M $3.46M $4.13M $6.48M
Common Stock -- -- $1.0K $1.0K $1.0K -- $3.0K $2.0K
Retained Earnings -$153.5M -$149.9M -$145.7M -$141.6M -$137.6M -$132.4M -$126.7M -$121.7M
Accumulated Other Comp. Income -$35K -$26K -$22K -$13K -$13K -$13K -$26K -$28K
Total Stockholders' Equity $1.63M $3.13M $4.93M $3.76M $6.92M $1.76M $6.94M $1.53M
Total Equity $1.63M $3.13M $4.93M $3.76M $7.20M $2.08M $7.30M $1.97M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$20.06M -$22.21M -$29.22M -$25.43M
Depreciation & Amortization $1.65M $1.53M $392K $260K
Stock-Based Compensation $2.11M $2.96M $4.81M $4.52M
Change in Receivables -- -- -- -$870
Change in Payables -$1.33M -$628K -$6.17M $1.62M
Operating Cash Flow -$21.29M -$19.69M -$26.98M -$13.21M
Purchases of Investments -$50K -- -- --
Investing Cash Flow -$170K -$16K -$478K -$494K
Financing Cash Flow $17.46M $27.36M $29.04M $12.09M
Net Change in Cash -$3.99M $7.64M $1.58M -$969K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.65M -$4.16M -$4.11M -$4.06M -$5.18M -$5.76M -$5.06M -$4.15M
Depreciation & Amortization $417K $438K $426K $423K $427K $407K $394K $98K
Stock-Based Compensation $62K $157K $231K $450K $529K $522K $607K $626K
Change in Payables $411K $74K $232K -$404K -$191K $19K -$752K -$1.17M
Operating Cash Flow -$2.34M -$4.35M -$4.12M -$5.04M -$4.24M -$4.88M -$7.13M -$5.42M
Investing Cash Flow -$23K -$33K -$5.0K -$79K -$27K -$57K -$7.0K -$5.0K
Financing Cash Flow $2.25M $1.83M $5.16M $340K $9.48M -$469K $8.11M $13.11M
Net Change in Cash -$124K -$2.56M $1.03M -$4.78M $5.21M -$5.40M $970K $7.69M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -51395.6%
Net Profit Margin -- -- -- -56504.4%
Return on Equity (ROE) -529.6% -1443.5% -- --
Return on Assets (ROA) -224.7% -156.1% -291.6% -979.1%
Current Ratio 1.59x 1.08x 0.42x 0.02x
Quick Ratio 1.42x 1.01x 0.19x 0.01x
Debt to Equity 0.68x 4.22x -- --
EPS Growth (YoY) -- -- -158.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -979.2% -557.7% -385.6% -529.6% -288.3% -1125.4% -286.8% -1443.5%
Return on Assets (ROA) -289.2% -242.5% -198.4% -224.7% -142.2% -212.3% -132.1% -156.1%
Current Ratio 1.27x 1.68x 1.92x 1.59x 2.12x 1.13x 2.12x 1.08x
Quick Ratio 1.06x 1.26x 1.73x 1.42x 2.00x 0.99x 1.95x 1.01x
Debt to Equity 0.63x 0.62x 0.46x 0.68x 0.42x 1.96x 0.59x 4.22x
Source: SEC EDGAR CompanyFacts (CIK 0001855485) · from June 30, 2021 Data through September 30, 2026 · synced Nov 21, 2026, 05:12 UTC · Open in terminal